World
New cancer therapy from Türkiye advances in clinical development
April 10, 2026
Daily Sabah
Scroll
A Türkiye-originated oncology drug candidate, RS-0139, has successfully completed its Phase 1 clinical trial, positioning itself as a key milestone in the country’s biotechnology a...
Daily Sabah
Coverage and analysis from Turkey. All insights are generated by our AI narrative analysis engine.
Turkey
Bias: right